Mirum Pharmaceuticals Opens Below IPO Price
Mirum Pharmaceuticals (NASDAQ: MIRM) made its public debut Thursday morning, opening at $13 after being priced at $15 per share.
The shares are listed on the Nasdaq and trading under the symbol MIRM.
Mirum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Citigroup, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering. Raymond James is acting as lead manager. Roth Capital Partners is acting as co-manager.
Related Links:
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
